12th Annual Quality Improvement and Patient Safety Conference

Needs Statement

Join us for the Baylor College of Medicine 12th Annual Quality Improvement and Patient Safety Conference, an event dedicated to advancing healthcare quality through innovation and collaboration. As medical errors continue to pose significant public health and ethical challenges, healthcare providers must prioritize patient safety and continuously enhance their quality of care.

This year’s theme, “High Value Care: Patient Experience and Provider Experience,” underscores the need to lead change across clinical systems in ways that advance quality improvement and produce measurable gains in patient health outcomes. Attendees will gain insights from expert-led sessions, real-world case studies, and discussions on providing safe, effective, and patient-centered services into clinical practice.

Educational Objectives

At the conclusion of this activity, the participant will be able to: 

• coming soon

Target Audience

Competencies

• Interprofessional Communication
• Professionalism
• Quality Improvement

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

Educational Methods

• Lectures
• Small Group Breakout Session

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credits™.

This activity provides opportunities to earn ABA, ABIM, ABOHNS, ABPath, ABP, ABS Maintenance of Certification (MOC) Part 2 Credits.

Texas Children’s Hospital is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. 

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.